Annual ROE
-156.45%
+65.11%+29.39%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual return on equity is -156.45%, with the most recent change of +65.11% (+29.39%) on December 31, 2023.
- During the last 3 years, IMNM annual ROE has fallen by -113.31% (-262.66%).
- IMNM annual ROE is now -602.73% below its all-time high of 31.12%, reached on December 31, 2018.
Performance
IMNM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-173.44%
+21.16%+10.87%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly return on equity is -173.44%, with the most recent change of +21.16% (+10.87%) on September 30, 2024.
- Over the past year, IMNM quarterly ROE has increased by +148.63% (+46.15%).
- IMNM quarterly ROE is now -308.41% below its all-time high of 83.22%, reached on June 30, 2020.
Performance
IMNM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
IMNM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.4% | +46.1% |
| 3 y3 years | -262.7% | -26.8% |
| 5 y5 years | -602.7% | -26.8% |
IMNM ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -205.1% | +29.4% | -253.5% | +46.1% |
| 5 y | 5-year | -633.8% | +29.4% | -308.4% | +95.6% |
| alltime | all time | -602.7% | +29.4% | -308.4% | +95.6% |
Immunome ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -173.44%(-10.9%) |
| Jun 2024 | - | -194.60%(-27.1%) |
| Mar 2024 | - | -266.86%(-17.1%) |
| Dec 2023 | -156.45%(-29.4%) | -322.07%(+68.4%) |
| Sep 2023 | - | -191.23%(+15.1%) |
| Jun 2023 | - | -166.17%(+18.1%) |
| Mar 2023 | - | -140.75%(+2.9%) |
| Dec 2022 | -221.56% | -136.79%(+29.0%) |
| Sep 2022 | - | -106.05%(+25.5%) |
| Jun 2022 | - | -84.50%(+31.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -64.46%(+31.4%) |
| Dec 2021 | -51.28%(+18.9%) | -49.06%(+14.0%) |
| Sep 2021 | - | -43.02%(-54.8%) |
| Jun 2021 | - | -95.15%(-51.0%) |
| Mar 2021 | - | -194.34%(-95.1%) |
| Dec 2020 | -43.14%(-247.2%) | -3981.47%(-6115.2%) |
| Sep 2020 | - | 66.19%(-20.5%) |
| Jun 2020 | - | 83.22%(+255.6%) |
| Mar 2020 | - | 23.40%(+47.4%) |
| Dec 2019 | 29.31%(-5.8%) | 15.88% |
| Dec 2018 | 31.12% | - |
FAQ
- What is Immunome annual return on equity?
- What is the all time high annual ROE for Immunome?
- What is Immunome annual ROE year-on-year change?
- What is Immunome quarterly return on equity?
- What is the all time high quarterly ROE for Immunome?
- What is Immunome quarterly ROE year-on-year change?
What is Immunome annual return on equity?
The current annual ROE of IMNM is -156.45%
What is the all time high annual ROE for Immunome?
Immunome all-time high annual return on equity is 31.12%
What is Immunome annual ROE year-on-year change?
Over the past year, IMNM annual return on equity has changed by +65.11% (+29.39%)
What is Immunome quarterly return on equity?
The current quarterly ROE of IMNM is -173.44%
What is the all time high quarterly ROE for Immunome?
Immunome all-time high quarterly return on equity is 83.22%
What is Immunome quarterly ROE year-on-year change?
Over the past year, IMNM quarterly return on equity has changed by +148.63% (+46.15%)